Nevro Corp. NVRO 5.38 Nevro Corp.

Home
⇒ 
Stock List ⇒ Nevro Corp.
Range:4.382-22.64Vol Avg:627010Last Div:0Changes:0.4
Beta:0.94Cap:0.20BCurrency:USDExchange:NYSE
Sector:HealthcareIPO:Thu Nov 06 2014Empoloyees:1215
CUSIP:64157F103CIK:0001444380ISIN:US64157F1030Country:US
CEO:Mr. Kevin R. ThornalWebsite:https://www.nevro.com
Nevro Corp., a medical device company, provides products for patients suffering from chronic pain in the United States and internationally. The company develops and commercializes the Senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic pain, as well as Senza II and Senza Omnia systems. It also provides 10 kHz Therapy, which delivers neuromodulation solutions for treating chronic pain based on available clinical evidence. The company sells its products through its direct sales force, and a network of sales agents and independent distributors. Nevro Corp. was incorporated in 2006 and is headquartered in Redwood City, California.
The content provided on this site is for informational purposes only and does not constitute financial, investment, or professional advice. We are not registered investment advisors or financial planners, and we do not provide recommendations or advice on buying, selling, or holding any particular stocks or securities. Any investment decisions should be made based on your own research and consultation with a qualified financial professional. We are not responsible for any financial loss or damages incurred from reliance on the information provided on this site. Please invest responsibly and seek professional advice when needed.
DMCA.com Protection StatusPowered by StackThrow